Real-life data on first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single center experience.

Alper Topal,Sezin Sayın,Ali Gokyer,Ahmet Kucukarda,Osman Kostek,Muhammet Bekir Hacıoglu,Sernaz Uzunoglu,Bulent Erdogan,Irfan Cicin

Journal of B.U.ON. : official journal of the Balkan Union of Oncology（2021）

引用 1|浏览17

暂无评分

摘要

High ECOG score, non-clear-cell histology, presence of liver metastasis in metastatic RCC patients were found to be associated with shorter OS and PFS. Sunitinib and pazopanib produced similar OS and PFS rates in first-line treatment of metastatic RCC.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要